These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 10652434

  • 1. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M.
    Int J Cancer; 2000 Feb 01; 85(3):407-15. PubMed ID: 10652434
    [Abstract] [Full Text] [Related]

  • 2. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.
    Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A, Albini A, Bologna M.
    Oncol Res; 1999 Feb 01; 11(1):17-31. PubMed ID: 10451028
    [Abstract] [Full Text] [Related]

  • 3. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
    Festuccia C, Guerra F, D'Ascenzo S, Giunciuglio D, Albini A, Bologna M.
    Int J Cancer; 1998 Jan 30; 75(3):418-31. PubMed ID: 9455804
    [Abstract] [Full Text] [Related]

  • 4. Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components.
    Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D, Teti A.
    Int J Cancer; 1999 May 05; 81(3):395-403. PubMed ID: 10209954
    [Abstract] [Full Text] [Related]

  • 5. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM, Waghray A.
    Clin Cancer Res; 1995 Jul 05; 1(7):755-61. PubMed ID: 9816042
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 05; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 7. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta.
    Shiou SR, Datta PK, Dhawan P, Law BK, Yingling JM, Dixon DA, Beauchamp RD.
    J Biol Chem; 2006 Nov 10; 281(45):33971-81. PubMed ID: 16959768
    [Abstract] [Full Text] [Related]

  • 8. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH, O'Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD.
    Surgery; 2003 May 10; 133(5):568-79. PubMed ID: 12773985
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.
    Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, Gulino A, Mackay AR.
    Int J Cancer; 1998 Mar 02; 75(5):721-30. PubMed ID: 9495240
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I, Baley PA, Thompson TC.
    Cancer Res; 1996 Jul 15; 56(14):3359-65. PubMed ID: 8764134
    [Abstract] [Full Text] [Related]

  • 11. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 15; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct 15; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.
    Thromb Haemost; 2005 May 15; 93(5):964-75. PubMed ID: 15886816
    [Abstract] [Full Text] [Related]

  • 14. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
    Uchima Y, Sawada T, Nishihara T, Maeda K, Ohira M, Hirakawa K.
    Pancreas; 2004 Aug 15; 29(2):123-31. PubMed ID: 15257104
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system.
    Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G, Gress TM.
    Int J Cancer; 2001 Jul 15; 93(2):204-11. PubMed ID: 11410867
    [Abstract] [Full Text] [Related]

  • 16. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
    Albo D, Berger DH, Vogel J, Tuszynski GP.
    J Gastrointest Surg; 1999 Jul 15; 3(4):411-7. PubMed ID: 10482694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
    Zhang H, Morisaki T, Matsunaga H, Sato N, Uchiyama A, Hashizume K, Nagumo F, Tadano J, Katano M.
    Clin Exp Metastasis; 2000 Jul 15; 18(4):343-52. PubMed ID: 11448066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.